130 related articles for article (PubMed ID: 18609106)
1. Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.
Nassar BA; Nanji AA; Ransom TP; Rockwood K; Kirkland SA; Macpherson K; Connelly PW; Johnstone DE; O'Neill BJ; Bata IR; Andreou P; Title LM
Scand J Clin Lab Invest; 2008; 68(4):286-91. PubMed ID: 18609106
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
[TBL] [Abstract][Full Text] [Related]
3. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
Niessner A; Marculescu R; Haschemi A; Endler G; Zorn G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
Thromb Haemost; 2005 May; 93(5):949-54. PubMed ID: 15886814
[TBL] [Abstract][Full Text] [Related]
4. Association of V249I and T280M polymorphisms in the chemokine receptor CX3CR1 gene with early onset of coronary artery disease among North Indians.
Singh N; Rai H; Sinha N; Kumar S; Pandey CM; Agrawal S
Genet Test Mol Biomarkers; 2012 Jul; 16(7):756-60. PubMed ID: 22731642
[TBL] [Abstract][Full Text] [Related]
5. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
[TBL] [Abstract][Full Text] [Related]
6. Association of polymorphisms in the chemokine receptor CX3CR1 gene with coronary artery disease.
Matzhold EM; Trummer O; Grünbacher G; Zulus B; Boehm BO; März W; Renner W
Cytokine; 2009 Sep; 47(3):224-7. PubMed ID: 19628406
[TBL] [Abstract][Full Text] [Related]
7. Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity.
Sirois-Gagnon D; Chamberland A; Perron S; Brisson D; Gaudet D; Laprise C
Obesity (Silver Spring); 2011 Jan; 19(1):222-7. PubMed ID: 20523302
[TBL] [Abstract][Full Text] [Related]
8. Improved prediction of early-onset coronary artery disease using APOE epsilon4, BChE-K, PPARgamma2 Pro12 and ENOS T-786C in a polygenic model.
Nassar BA; Rockwood K; Kirkland SA; Ransom TP; Darvesh S; MacPherson K; Johnstone DE; O'Neill BJ; Bata IR; Andreou P; Jeffery JS; Cox JL; Title LM
Clin Biochem; 2006 Feb; 39(2):109-14. PubMed ID: 16298355
[TBL] [Abstract][Full Text] [Related]
9. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
10. Endothelial nitric oxide synthase and fractalkine chemokine receptor polymorphisms on angiographically assessed coronary atherosclerosis.
Rios DL; Callegari-Jacques SM; Hutz MH
Clin Chim Acta; 2005 Dec; 362(1-2):138-46. PubMed ID: 16026776
[TBL] [Abstract][Full Text] [Related]
11. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease.
Hattori H; Ito D; Tanahashi N; Murata M; Saito I; Watanabe K; Suzuki N
Neurosci Lett; 2005 Feb; 374(2):132-5. PubMed ID: 15644279
[TBL] [Abstract][Full Text] [Related]
12. T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis.
Amanatidou V; Sourvinos G; Apostolakis S; Tsilimigaki A; Spandidos DA
Pediatr Infect Dis J; 2006 May; 25(5):410-4. PubMed ID: 16645504
[TBL] [Abstract][Full Text] [Related]
13. Internal carotid artery occlusive disease and polymorphisms of fractalkine receptor CX3CR1: a genetic risk factor.
Ghilardi G; Biondi ML; Turri O; Guagnellini E; Scorza R
Stroke; 2004 Jun; 35(6):1276-9. PubMed ID: 15118174
[TBL] [Abstract][Full Text] [Related]
14. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.
Apostolakis S; Baritaki S; Kochiadakis GE; Igoumenidis NE; Panutsopulos D; Spandidos DA
Thromb Res; 2007; 119(1):63-71. PubMed ID: 16480760
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.
Moatti D; Faure S; Fumeron F; Amara Mel-W; Seknadji P; McDermott DH; Debré P; Aumont MC; Murphy PM; de Prost D; Combadière C
Blood; 2001 Apr; 97(7):1925-8. PubMed ID: 11264153
[TBL] [Abstract][Full Text] [Related]
16. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
17. Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease.
Yadav AK; Kumar V; Jha V
Indian J Nephrol; 2016; 26(4):275-9. PubMed ID: 27512300
[TBL] [Abstract][Full Text] [Related]
18. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
Rasouli M; Kiasari AM
Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
[TBL] [Abstract][Full Text] [Related]
19. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine receptor polymorphisms V2491 and T280M as genetic risk factors for restenosis.
Niessner A; Marculescu R; Kvakan H; Haschemi A; Endler G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
Thromb Haemost; 2005 Dec; 94(6):1251-6. PubMed ID: 16411402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
